Barclays Maintains Teladoc Health(TDOC.US) With Buy Rating, Maintains Target Price $10
Truist Financial Maintains Teladoc Health(TDOC.US) With Hold Rating
BofA Securities Maintains Teladoc Health(TDOC.US) With Hold Rating, Maintains Target Price $9.5
Teladoc Health Is Maintained at Hold by Jefferies
Teladoc Health Analyst Ratings
Jefferies Maintains Teladoc Health(TDOC.US) With Hold Rating, Cuts Target Price to $10
D.A. Davidson Maintains Teladoc Health(TDOC.US) With Hold Rating
BofA Securities Maintains Teladoc Health(TDOC.US) With Hold Rating, Maintains Target Price $9.5
Teladoc Health Price Target Cut to $9.00/Share From $16.00 by JP Morgan
Teladoc Health Analyst Ratings
J.P. Morgan Maintains Teladoc Health(TDOC.US) With Hold Rating, Cuts Target Price to $9
Teladoc Health Analyst Ratings
BofA Securities Maintains Teladoc Health(TDOC.US) With Hold Rating, Announces Target Price $9.5
Teladoc Health Analyst Ratings
Teladoc (TDOC) Gets a Buy From Piper Sandler
Piper Sandler Maintains Teladoc Health(TDOC.US) With Buy Rating, Cuts Target Price to $10
Teladoc Health Analyst Ratings
Teladoc Health Price Target Cut to $10.00/Share From $15.00 by Truist Securities
Deutsche Bank Cuts Teladoc Price Target to $10 From $15, Maintains Hold Rating
A Quick Look at Today's Ratings for Teladoc Health(TDOC.US), With a Forecast Between $10 to $17